A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies

Evan J. Wuthrick, Mitchell Kamrava, Walter J. Curran, Maria Werner-Wasik, Kevin A. Camphausen, Terry Hyslop, Rita Axelrod, David W. Andrews, Jon Glass, Mitchell MacHtay, Adam P. Dicker

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint Dive into the research topics of 'A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences